Different contribution of bovine papillomavirus type 1 oncoproteins to the transformation of equine fibroblasts

Journal of General Virology

Volumn 92, Issue 4, 2011, Pages 773-783

  Yuan, ZhengQiang ^a   Gault, Elizabeth A ^a   Saveria Campo, M ^a   Nasir, Lubna ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN E5; PROTEIN E6; PROTEIN E7; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; CELL IMMORTALIZATION; CELL INVASION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HORSE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION; VIRUS GENE;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EQUIDAE; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; ONCOGENE PROTEINS, VIRAL;

BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PAPILLOMAVIRUS TYPE 2; EQUIDAE;

EID: 79955776128     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.028191-0     Document Type: Article

References (63)

1. Akgül, B., García-Escudero, R., Ghali, L., Pfister, H. J., Fuchs, P. G., Navsaria, H. & Storey, A. (2005). The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res 65, 2216-2223.
2. Argyle, D., Ellsmore, V., Gault, E. A., Munro, A. F. & Nasir, L. (2003).Equine telomeres and telomerase in cellular immortalisation and ageing. Mech Ageing Dev 124, 759-764.
3. Birkedal-Hansen, H. (1995). Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7, 728-735.
4. Bohl, J., Hull, B. & Vande Pol, S. B. (2001). Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins. J Virol 75, 513-521.
5. Borzacchiello, G., Iovane, G., Marcante, M. L., Poggiali, F., Roperto, F., Roperto, S. & Venuti, A. (2003). Presence of bovine papillomavirus type 2 DNA and expression of the viral oncoprotein E5 in naturally occurring urinary bladder tumours in cows. J Gen Virol 84, 2921-2926.
6. Borzacchiello, G., Russo, V., Gentile, F., Roperto, F., Venuti, A., Nitsch, L., Campo, M. S. & Roperto, S. (2006). Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor b receptor in naturally occurring bovine urinary bladder tumours. Oncogene 25, 1251-1260.
7. Borzacchiello, G., Russo, V., Della Salda, L., Roperto, S. & Roperto, F. (2008). Expression of platelet-derived growth factor-b receptor and bovine papillomavirus E5 and E7 oncoproteins in equine sarcoid. J Comp Pathol 139, 231-237.
8. Borzacchiello, G., Mogavero, S., De Vita, G., Roperto, S., Della Salda, L. & Roperto, F. (2009). Activated platelet-derived growth factor b receptor expression, PI3K-AKT pathway molecular analysis, and transforming signals in equine sarcoids. Vet Pathol 46, 589-597.
9. Broccoli, D., Young, J. W. & de Lange, T. (1995). Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 92, 9082-9086.
10. Campo, M. S. (2006). Bovine papillomavirus: old system, new lessons? In Papillomvirus Research: From Natural History to Vaccines and Beyond, pp. 373-387. Edited by M. S. Campo. Norfolk, UK: Caister Academic Press.
11. Carr, E. A., Théon, A. P., Madewell, B. R., Griffey, S. M. & Hitchcock, M. E. (2001). Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States. Am J Vet Res 62, 741-744.
12. Chambers, G., Ellsmore, V. A., O'Brien, P. M., Reid, S. W., Love, S., Campo, M. S. & Nasir, L. (2003a). Association of bovine papillomavirus with the equine sarcoid. J Gen Virol 84, 1055-1062.
13. Chambers, G., Ellsmore, V. A., O'Brien, P. M., Reid, S. W., Love, S., Campo, M. S. & Nasir, L. (2003b). Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res 96, 141-145.
14. Choudhury, G. G., Karamitsos, C., Hernandez, J., Gentilini, A., Bardgette, J. & Abboud, H. E. (1997). PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF. Am J Physiol 273, F931-F938.
15. DeMali, K. A., Whiteford, C. C., Ulug, E. T. & Kazlauskas, A. (1997). Platelet-derived growth factor-dependent cellular transformation requires either phospholipase Cc or phosphatidylinositol 3 kinase. J Biol Chem 272, 9011-9018.
16. DeMasi, J., Huh, K. W., Nakatani, Y., Münger, K. & Howley, P. M. (2005). Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proc Natl Acad Sci U S A 102, 11486-11491.
17. Friedl, P. & Wolf, K. (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3, 362-374.
18. Fujii, T., Saito, M., Iwasaki, E., Ochiya, T., Takei, Y., Hayashi, S., Ono, A., Hirao, N., Nakamura, M. & other authors (2006). Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Int J Oncol 29, 541-548.
19. Gobeil, P. A., Yuan, Z., Gault, E. A., Morgan, I. M., Campo, M. S. & Nasir, L. (2009). Small interfering RNA targeting bovine papillomavirus type 1 E2 induces apoptosis in equine sarcoid transformed fibroblasts. Virus Res 145, 162-165.
20. Gu, W., Putral, L. & McMillan, N. (2008). siRNA and shRNA as anticancer agents in a cervical cancer model. Methods Mol Biol 442, 159-172.
21. Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M. & other authors (1994). Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 59, 307-315.
22. Hennigan, R. F., Hawker, K. L. & Ozanne, B. W. (1994). Fostransformation activates genes associated with invasion. Oncogene 9, 3591-3600.
23. Jackson, C. (1936). The incidence and pathology of tumours of domestic animals in South Africa. Ondesterpoort J Vet Sci Anim Ind 6, 378-385.
24. Jia, R. & Zheng, Z. M. (2009). Regulation of bovine papillomavirus type 1 gene expression by RNA processing. Front Biosci 14, 1270-1282.
25. Jonson, A. L., Rogers, L. M., Ramakrishnan, S. & Downs, L. S., Jr (2008). Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Gynecol Oncol 111, 356-364.
26. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L. & Shay, J. W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
27. Kim, S. J., Kim, S. Y., Kwon, C. H. & Kim, Y. K. (2007). Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells. Growth Factors 25, 77-86.
28. Kleiner, D. E. & Stetler-Stevenson, W. G. (1994). Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218, 325-329.
29. Klingelhutz, A. J., Foster, S. A. & McDougall, J. K. (1996). Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79-82.
30. Knottenbelt, D. C. (2005). A suggested clinical classification of the equine sarcoid. Clin Tech Equine Pract 4, 278-295.
31. Lambert, P. F., Baker, C. C. & Howley, P. M. (1988). The genetics of bovine papillomavirus type 1. Annu Rev Genet 22, 235-258.
32. Lavach, J. D., Sullins, K. E., Roberts, S. M., Severin, G. A., Wheeler, C. & Lueker, D. C. (1985). BCG treatment of periocular sarcoid. Equine Vet J 17, 445-448.
33. Marchetti, B., Gault, E. A., Cortese, M. S., Yuan, Z., Ellis, S. A., Nasir, L. & Campo, M. S. (2009). Bovine papillomavirus type 1 oncoprotein E5 inhibits equine MHC class I and interacts with equine MHC I heavy chain. J Gen Virol 90, 2865-2870.
34. Martens, A., De Moor, A., Demeulemeester, J. & Ducatelle, R. (2000).Histopathological characteristics of five clinical types of equine sarcoid. Res Vet Sci 69, 295-300.
35. Martens, A., De Moor, A., Demeulemeester, J. & Peelman, L. (2001a). Polymerase chain reaction analysis of the surgical margins of equine sarcoids for bovine papilloma virus DNA. Vet Surg 30, 460-467.
36. Martens, A., De Moor, A. & Ducatelle, R. (2001b). PCR detection of bovine papilloma virus DNA in superficial swabs and scrapings from equine sarcoids. Vet J 161, 280-286.
37. Morin, G. B. (1989). The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521-529.
38. Nasir, L. & Reid, S. W. (1999). Bovine papillomaviral gene expression in equine sarcoid tumours. Virus Res 61, 171-175.
39. Neary, K. & DiMaio, D. (1989). Open reading frames E6 and E7 of bovine papillomavirus type 1 are both required for full transformation of mouse C127 cells. J Virol 63, 259-266.
40. Otten, N., von Tscharner, C., Lazary, S., Antczak, D. F. & Gerber, H. (1993). DNA of bovine papillomavirus type 1 and 2 in equine sarcoids: PCR detection and direct sequencing. Arch Virol 132, 121-131.
41. Park, J. S., Boyer, S., Mitchell, K., Gilfor, D., Birrer, M., Darlington, G., El Deiry, W., Firestone, G. L., Munger, K. & other authors (2000). Expression of human papilloma virus E7 protein causes apoptosis and inhibits DNA synthesis in primary hepatocytes via increased expression of p21Cip-1/WAF1/MDA6. J Biol Chem 275, 18-28.
42. Pascoe, R. R. & Summers, P. M. (1981). Clinical survey of tumours and tumour-like lesions in horses in south east Queensland. EquineVet J 13, 235-239.
43. Pennie, W. D., Grindlay, G. J., Cairney, M. & Campo, M. S. (1993).Analysis of the transforming functions of bovine papillomavirus type 4. Virology 193, 614-620.
44. Petti, L. & DiMaio, D. (1994). Specific interaction between the bovine papillomavirus E5 transforming protein and the b receptor for platelet-derived growth factor in stably transformed and acutely transfected cells. J Virol 68, 3582-3592.
45. Ragland, W. L. & Spencer, G. R. (1969). Attempts to relate bovine papilloma virus to the cause of equine sarcoid: Equidae inoculated intradermally with bovine papilloma virus. Am J Vet Res 30, 743-752.
46. Ragland, K. W. L., III, Keown, G. F. H. & Spencer, G. R. (1970). Equine sarcoid. Equine Vet J 2, 2-11.
47. Reid, S. W., Smith, K. T. & Jarrett, W. F. (1994). Detection, cloning and characterisation of papillomaviral DNA present in sarcoid tumours of Equus asinus. Vet Rec 135, 430-432.
48. Sahai, E. & Marshall, C. J. (2003). Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5, 711-719.
49. Schiller, J. T., Vass, W. C. & Lowy, D. R. (1984). Identification of a second transforming region in bovine papillomavirus DNA. Proc Natl Acad Sci U S A 81, 7880-7884.
50. Shay, J. W. & Bacchetti, S. (1997). A survey of telomerase activity in human cancer. Eur J Cancer 33, 787-791.
51. Singh, P. K., Wen, Y., Swanson, B. J., Shanmugam, K., Kazlauskas, A., Cerny, R. L., Gendler, S. J. & Hollingsworth, M. A. (2007). Plateletderived growth factor receptor b-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells. Cancer Res 67, 5201-5210.
52. Suprynowicz, F. A., Disbrow, G. L., Simic, V. & Schlegel, R. (2005).Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? Virology 332, 102-113.
53. Tanaga, K., Bujo, H., Zhu, Y., Kanaki, T., Hirayama, S., Takahashi, K., Inoue, M., Mikami, K., Schneider, W. J. & Saito, Y. (2004). LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors. Arterioscler Thromb Vasc Biol 24, 1422-1428.
54. Tarwid, J. N., Fretz, P. B. & Clark, E. G. (1985). Equine sarcoids: a study with emphasis on pathologic diagnosis. Compend Contin Educ 7, S293-S301.
55. Tong, X., Salgia, R., Li, J. L., Griffin, J. D. & Howley, P. M. (1997). The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. J Biol Chem 272, 33373-33376.
56. Westermarck, J. & Kähäri, V. M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13, 781-792.
57. Yasmeen, A., Bismar, T. A., Kandouz, M., Foulkes, W. D., Desprez, P.-Y. & Al Moustafa, A.-E. (2007). E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle 6, 2038-2042.
58. Yuan, Z., Gallagher, A., Gault, E. A., Campo, M. S. & Nasir, L. (2007). Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers. Vet J 174, 599-604.
59. Yuan, Z. Q., Gault, E. A., Gobeil, P., Nixon, C., Campo, M. S. & Nasir, L. (2008a). Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology 373, 352-361.
60. Yuan, Z. Q., Nicolson, L., Marchetti, B., Gault, E. A., Campo, M. S. & Nasir, L. (2008b). Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol 82, 6481-6491.
61. Yuan, Z., Gobeil, P. A., Campo, M. S. & Nasir, L. (2010a). Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive. Virology 396, 143-151.
62. Yuan, Z. Q., Bennett, L., Campo, M. S. & Nasir, L. (2010b). Bovine papillomavirus type 1 E2 and E7 proteins down-regulate Toll Like Receptor 4 (TLR4) expression in equine fibroblasts. Virus Res 149, 124-127.
63. Zimmermann, H., Koh, C. H., Degenkolbe, R., O'Connor, M. J., Müller, A., Steger, G., Chen, J. J., Lui, Y., Androphy, E. & Bernard, H. U. (2000). Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. J Gen Virol 81, 2617-2623.